Inhalation of peptide-loaded nanoparticles improves heart failure

Science Translational Medicine

Volumn 10, Issue 424, 2018, Pages

  Miragoli, Michele ^a,b,c   Ceriotti, Paola ^a,c   Iafisco, Michele ^d   Vacchiano, Marco ^a   Salvarani, Nicolò ^a,c   Alogna, Alessio ^e,f   Carullo, Pierluigi ^a,c   Ramirez Rodríguez, Gloria Belén ^d   Patrício, Tatiana ^d   Degli Esposti, Lorenzo ^d   Rossi, Francesca ^g   Ravanetti, Francesca ^b   Pinelli, Silvana ^b   Alinovi, Rossella ^b   Erreni, Marco ^a,h   Rossi, Stefano ^b   Condorelli, Gianluigi ^a,c,h   Post, Heiner ^e,i   Tampieri, Anna ^d   Catalucci, Daniele ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c Milan Unit   (Italy)

^d INSTITUTE OF SCIENCE AND TECHNOLOGY FOR CERAMICS   (Italy)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f BERLIN INSTITUTE OF HEALTH   (Germany)

^g IMEM CNR   (Italy)

^h HUMANITAS UNIVERSITY   (Italy)

ⁱ St Marien Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; NANOPARTICLE; PEPTIDOMIMETIC AGENT; DRUG CARRIER; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION; INHALATION; MALE; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PARTICLE SIZE; PIG; PRIORITY JOURNAL; RAT; TRACHEOBRONCHIAL TREE; ANIMAL; C57BL MOUSE; CHEMISTRY; ECHOCARDIOGRAPHY; INHALATIONAL DRUG ADMINISTRATION; WISTAR RAT;

ADMINISTRATION, INHALATION; ANIMALS; CALCIUM PHOSPHATES; DRUG CARRIERS; ECHOCARDIOGRAPHY; HEART FAILURE; MALE; MICE; MICE, INBRED C57BL; NANOPARTICLES; PEPTIDES; RATS; RATS, WISTAR; SWINE;

EID: 85040862938     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aan6205     Document Type: Article

References (28)

1. M. Giardiello, N. J. Liptrott, T. O. McDonald, D. Moss, M. Siccardi, P. Martin, D. Smith, R. Gurjar, S. P. Rannard, A. Owen, Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies. Nat. Commun. 7, 13184 (2016).
2. B. Y. S. Kim, J. T. Rutka, W. C. W. Chan, Nanomedicine. N. Engl. J. Med. 363, 2434–2443 (2010).
3. M. E. Davis, J. E. Zuckerman, C. H. J. Choi, D. Seligson, A. Tolcher, C. A. Alabi, Y. Yen, J. D. Heidel, A. Ribas, Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464, 1067–1070 (2010).
4. V. Weissig, T. K. Pettinger, N. Murdock, Nanopharmaceuticals (part 1): Products on the market. Int. J. Nanomed. 9, 4357–4373 (2014).
5. R. Kuai, L. J. Ochyl, K. S. Bahjat, A. Schwendeman, J. J. Moon, Designer vaccine nanodiscs for personalized cancer immunotherapy. Nat. Mater. 16, 489–496 (2017).
6. Y. Zhao, F. Fay, S. Hak, J. Manuel Perez-Aguilar, B. L. Sanchez-Gaytan, B. Goode, R. Duivenvoorden, C. de Lange Davies, A. Bjørkøy, H. Weinstein, Z. A. Fayad, C. Pérez-Medina, W. J. M. Mulder, Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy. Nat. Commun. 7, 11221 (2016).
7. E. Blanco, H. Shen, M. Ferrari, Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33, 941–951 (2015).
8. Y. T. Ho, B. Poinard, J. C. Y. Kah, Nanoparticle drug delivery systems and their use in cardiac tissue therapy. Nanomedicine 11, 693–714 (2016).
9. C. W. Evans, K. S. Iyer, L. C. Hool, The potential for nanotechnology to improve delivery of therapy to the acute ischemic heart. Nanomedicine 11, 817–832 (2016).
10. S. S. Behera, K. Pramanik, M. K. Nayak, Recent advancement in the treatment of cardiovascular diseases: Conventional therapy to nanotechnology. Curr. Pharm. Des. 21, 4479–4497 (2015).
11. S. Mendis, S. Davis, B. Norrving, Organizational update: The world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke 46, e121–e122 (2015).
12. S. Suarez, A. Almutairi, K. L. Christman, Micro- and nanoparticles for treating cardiovascular disease. Biomater. Sci. 3, 564–580 (2015).
13. K. Fosgerau, T. Hoffmann, Peptide therapeutics: Current status and future directions. Drug Discov. Today 20, 122–128 (2015).
14. T. Uhlig, T. Kyprianou, F. G. Martinelli, C. A. Oppici, D. Heiligers, D. Hills, X. R. Calvo, P. Verhaert, The emergence of peptides in the pharmaceutical business: From exploration to exploitation. EuPA Open Proteom. 4, 58–69 (2014).
15. V. Di Mauro, M. Iafisco, N. Salvarani, M. Vacchiano, P. Carullo, G. B. Ramírez-Rodríguez, T. Patrício, A. Tampieri, M. Miragoli, D. Catalucci, Bioinspired negatively charged calcium phosphate nanocarriers for cardiac delivery of microRNAs. Nanomedicine 11, 891–906 (2016).
16. M. Savi, S. Rossi, L. Bocchi, L. Gennaccaro, F. Cacciani, A. Perotti, D. Amidani, R. Alinovi, M. Goldoni, I. Aliatis, P. P. Lottici, D. Bersani, M. Campanini, S. Pinelli, M. Petyx, C. Frati, A. Gervasi, K. Urbanek, F. Quaini, A. Buschini, D. Stilli, C. Rivetti, E. Macchi, A. Mutti, M. Miragoli, M. Zaniboni, Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue. Part. Fibre Toxicol. 11, 63 (2014).
17. N. L. Mills, K. Donaldson, P. W. Hadoke, N. A. Boon, W. MacNee, F. R. Cassee, T. Sandström, A. Blomberg, D. E. Newby, Adverse cardiovascular effects of air pollution. Nat. Clin. Pract. Cardiovasc. Med. 6, 36–44 (2009).
18. M. Miragoli, P. Novak, P. Ruenraroengsak, A. I. Shevchuk, Y. E. Korchev, M. J. Lab, T. D. Tetley, J. Gorelik, Functional interaction between charged nanoparticles and cardiac tissue: A new paradigm for cardiac arrhythmia? Nanomedicine 8, 725–737 (2013).
19. S. Bakand, A. Hayes, F. Dechsakulthorn, Nanoparticles: A review of particle toxicology following inhalation exposure. Inhal. Toxicol. 24, 125–135 (2012).
20. W. H. De Jong, P. J. Borm, Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomed. 3, 133–149 (2008).
21. J. R. Roberts, W. McKinney, H. Kan, K. Krajnak, D. G. Frazer, T. A. Thomas, S. Waugh, A. Kenyon, R. I. MacCuspie, V. A. Hackley, V. Castranova, Pulmonary and cardiovascular responses of rats to inhalation of silver nanoparticles. J. Toxicol. Environ. Health A 76, 651–668 (2013).
22. L. Petrick, M. Rosenblat, N. Paland, M. Aviram, Silicon dioxide nanoparticles increase macrophage atherogenicity: Stimulation of cellular cytotoxicity, oxidative stress, and triglycerides accumulation. Environ. Toxicol. 31, 713–723 (2016).
23. K. Lin, C. Wu, J. Chang, Advances in synthesis of calcium phosphate crystals with controlled size and shape. Acta Biomater. 10, 4071–4102 (2014).
24. F. Rusconi, P. Ceriotti, M. Miragoli, P. Carullo, N. Salvarani, M. Rocchetti, E. Di Pasquale, S. Rossi, M. Tessari, S. Caprari, M. Cazade, P. Kunderfranco, J. Chemin, M.-L. Bang, F. Polticelli, A. Zaza, G. Faggian, G. Condorelli, D. Catalucci, Peptidomimetic targeting of Cav2 overcomes dysregulation of the L-type calcium channel density and recovers cardiac function. Circulation 134, 534–546 (2016).
25. L. P. Kozlowski, IPC—Isoelectric point calculator. Biol. Direct 11, 55 (2016).
26. J. S. Patton, C. S. Fishburn, J. G. Weers, The lungs as a portal of entry for systemic drug delivery. Proc. Am. Thorac. Soc. 1, 338–344 (2004).
27. M. Irngartinger, V. Camuglia, M. Damm, J. Goede, H. W. Frijlink, Pulmonary delivery of therapeutic peptides via dry powder inhalation: Effects of micronisation and manufacturing. Eur. J. Pharm. Biopharm. 58, 7–14 (2004).
28. A. Alogna, M. Manninger, M. Schwarzl, B. Zirngast, P. Steendijk, J. Verderber, D. Zweiker, H. Maechler, B. M. Pieske, H. Post, Inotropic effects of experimental hyperthermia and hypothermia on left ventricular function in pigs—Comparison with dobutamine. Crit. Care Med. 44, e158–e167 (2016).